An open-label pilot study of the efficacy and tolerability of once- daily didanosine versus twice-daily didanosine

Clinical Infectious Diseases

Volumn 27, Issue 2, 1998, Pages 400-401

  Keiser, P ^a   Turner, D ^a   Ramilo, O ^a   Kvanli, M B ^a   Smith, J W ^a   Nassar, N ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0031904549     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517700     Document Type: Article

References (9)